Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Sale |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Third Rock Ventures III L.P. | 186,423 0.400% |
-5,279,211 (-96.59%) |
Filing History |
| 2024-02-14 4:19 pm Unchanged |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Third Rock Ventures III L.P. | 2,343,154 3.800% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:15 pm Unchanged |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 2,132,867 3.600% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 2,132,867 4.400% |
-3,706,293 (-63.47%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Third Rock Ventures III L.P. | 2,343,154 4.500% |
-1,703,271 (-42.09%) |
Filing History |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 184,544 0.400% |
-2,366,213 (-92.77%) |
Filing History |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Third Rock Ventures III L.P. | 1,939,692 2.200% |
-3,713,598 (-65.69%) |
Filing History |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Third Rock Ventures III L.P. | 5,465,634 14.200% |
-3,953,663 (-41.97%) |
Filing History |
| 2022-02-14 5:06 pm Sale |
2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Third Rock Ventures III L.P. | 4,046,425 10.000% |
-1,915,777 (-32.13%) |
Filing History |
| 2022-02-14 5:03 pm Purchase |
2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
Third Rock Ventures III L.P. | 3,139,685 12.600% |
3,139,685 (New Position) |
Filing History |
| 2022-02-14 5:02 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Third Rock Ventures III L.P. | 5,653,290 7.700% |
-3,295,779 (-36.83%) |
Filing History |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 2,550,757 5.700% |
-2,871,792 (-52.96%) |
Filing History |
| 2022-02-14 4:52 pm Sale |
2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
Third Rock Ventures III L.P. | 362,619 0.300% |
-10,188,496 (-96.56%) |
Filing History |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 5,839,160 16.500% |
5,839,160 (New Position) |
Filing History |
| 2021-02-16 4:15 pm Purchase |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 5,422,549 14.000% |
5,422,549 (New Position) |
Filing History |
| 2021-02-16 4:12 pm Purchase |
2020-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
Third Rock Ventures III L.P. | 10,551,115 11.700% |
10,551,115 (New Position) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Third Rock Ventures III L.P. | 8,949,069 13.500% |
8,949,069 (New Position) |
Filing History |